Assignee
LILLY ICOS LLC
US·25 granted patents·3 pending applications·418 citations·filing 2000–2006
Top patents by PatentIndex Score
28 records- 0192US6821975B1Beta-carboline drug productsLILLY ICOS LLC·Filed 2000·Granted Nov 23, 2004·70 cites·11 claims
- 0289US6943166B1Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunctionLILLY ICOS LLC·Filed 2000·Granted Sep 13, 2005·49 cites·12 claims
- 0389US6872721B2Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dioneLILLY ICOS LLC·Filed 2001·Granted Mar 29, 2005·37 cites·21 claims
- 0487US7182958B1β-carboline pharmaceutical compositionsLILLY ICOS LLC·Filed 2000·Granted Feb 27, 2007·35 cites·32 claims
- 0586US6825197B2Cyclic GMP-specific phosphodiesterase inhibitorsLILLY ICOS LLC·Filed 2001·Granted Nov 30, 2004·27 cites·18 claims
- 0683US7115621B2Chemical compoundsLILLY ICOS LLC·Filed 2002·Granted Oct 3, 2006·20 cites·39 claims
- 0783US6838456B2Condensed pyridoindole derivativesLILLY ICOS LLC·Filed 2001·Granted Jan 4, 2005·21 cites·26 claims
- 0882US6992192B2Carboline derivatives as PDE5 inhibitorsLILLY ICOS LLC·Filed 2002·Granted Jan 31, 2006·17 cites·13 claims
- 0981US7098209B2Pyrazino [1'2':1,6 ] pyrido [3, 4-b] indole-1,4-dione derivativesLILLY ICOS LLC·Filed 2002·Granted Aug 29, 2006·15 cites·18 claims
- 1081US7022856B2Carboline derivativesLILLY ICOS LLC·Filed 2001·Granted Apr 4, 2006·18 cites·18 claims
- 1180US7122554B2Carboline derivativesLILLY ICOS LLC·Filed 2002·Granted Oct 17, 2006·17 cites·23 claims
- 1280US6878711B2Indole derivatives as PDE5-inhibitorsLILLY ICOS LLC·Filed 2001·Granted Apr 12, 2005·14 cites·19 claims
- 1379US6841167B1β-carboline pharmaceutical compositionsLILLY ICOS LLC·Filed 2000·Granted Jan 11, 2005·14 cites·14 claims
- 1478US6911542B2Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivativesLILLY ICOS LLC·Filed 2001·Granted Jun 28, 2005·12 cites·1 claims
- 1578US6903099B2Condensed pyrazindione derivativesLILLY ICOS LLC·Filed 2001·Granted Jun 7, 2005·11 cites·14 claims
- 1677US6858620B2Condensed pyridoindole derivativesLILLY ICOS LLC·Filed 2001·Granted Feb 22, 2005·11 cites·18 claims
- 1774US6451807B1Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitorLILLY ICOS LLC·Filed 2000·Granted Sep 17, 2002·12 cites·7 claims
- 1869US7550479B2Modified Pictet-Spengler reaction and products prepared therefromLILLY ICOS LLC·Filed 2003·Granted Jun 23, 2009·4 cites·5 claims
- 1969US6962918B2Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunctionLILLY ICOS LLC·Filed 2001·Granted Nov 8, 2005·4 cites·18 claims
- 2067US7034027B2Fused heterocyclic derivatives as phosphodiesterase inhibitorsLILLY ICOS LLC·Filed 2001·Granted Apr 25, 2006·3 cites·21 claims
- 2165US6984641B2Carboline derivatives as PDE5 inhibitorsLILLY ICOS LLC·Filed 2002·Granted Jan 10, 2006·2 cites·5 claims
- 2265US6960587B2Condensed pyrazindione derivatives as PDE inhibitorsLILLY ICOS LLC·Filed 2001·Granted Nov 1, 2005·2 cites·20 claims
- 2357US6613768B1Treatment of female arousal disorderLILLY ICOS LLC·Filed 2000·Granted Sep 2, 2003·3 cites·4 claims
- 2454US2003144296A1Daily treatment for erectile dysfunction using a PDE5 inhibitorLILLY ICOS LLC·Filed 2003·Application pending·0 cites
- 2547US2007093493A1Treatment of benign prostatic hypertrophy and lower urinary tract symptomsLILLY ICOS LLC·Filed 2006·Application pending·0 cites
- 2642US7105506B2Tetracyclic compounds as PDE5-inhibitorsLILLY ICOS LLC·Filed 2002·Granted Sep 12, 2006·0 cites·26 claims
- 2742US2003100478A1Articles of manufactureLILLY ICOS LLC·Filed 2002·Application pending·0 cites
- 2819US7338955B1Medicament for treatment of neuropathiesLILLY ICOS LLC·Filed 2000·Granted Mar 4, 2008·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when LILLY ICOS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →